Aptar PharmaBrand LaunchAptar Digital Health Announces Stallergenes Greer iPUMP LaunchAptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Suppor...
Aptar PharmaCompany NewsAptar Pharma Completes First Phase of Global Injectables Expansion ProgramThe multisite, international expansion project began in 2020 and is intended to significantly boost ...
Aptar PharmaProduct InfoAptar CSP Technologies to Preview Activ-Vial™ Technology with PCR (Post-Consumer-Recycled) Content at SupplySide WestAptar CSP Technologies to preview Activ-Vial™ technology with PCR (Post-Consumer-Recycled) content a...
Aptar PharmaCompany NewsAptar Pharma highlights Innovative Drug Delivery Solutions at CPhI EuropeFrom October 24th to 26th, 2023, in Barcelona, Spain, Aptar Pharma will showcase its diverse portfol...
Aptar PharmaProduct InfoAptar Pharma Launches First Metal-Free Highly Recyclable Nasal Spray PumpAptar Pharma announces the launch of APF Futurity, its first metal-free, multidose nasal spray pump ...
Aptar PharmaBrand LaunchAptar Pharma granted exclusive license option by Pharmaxis to develop and promote high payload dry powder inhalerAptar Pharma have entered into an agreement with Pharmaxis, a clinical stage drug developer, under w...
Aptar PharmaCompany NewsAptar Pharma Acquires Worldwide License for Orbital™ High Payload Dry Powder InhalerAptar Pharma today has acquired the worldwide rights to clinical stage drug developer Pharmaxis’ pro...
Aptar PharmaCompany NewsAptar Pharma and i2c Pharmaceutical Services Announce Exclusive PartnershipAptar Pharma and i2c Pharmaceutical Services have announced an exclusive partnership to co-develop a...
Aptar PharmaCompany NewsAptar Pharma is finalist for four CPhI pharma awardsAptar Pharma is proud to be a Finalist for four Digital CPhI Pharma Awards at this year’s event. For...
Aptar PharmaCompany NewsAptar Pharma Announces Collaboration with TFF PharmaceuticalsAptar Pharma announces collaboration with TFF Pharmaceuticals to develop intranasal delivery of dry ...
Aptar PharmaProduct InfoFirst Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar’s Nasal Pump SystemAptar Pharma’s patented Cartridge Pump System (CPS), was recently reviewed by the U.S. FDA as the dr...
Aptar PharmaYouTube VideoAptar Pharma PremiumCoat: Accelerating & derisking injectable drug developmentDiscover PremiumCoat, Aptar Pharma’s ETFE film-coated platform of vial stoppers, syringe components ...
Aptar PharmaYouTube VideoUnderstanding Aptar Pharma’s Airless Drug Delivery SystemsFind out why Aptar Pharma’s proven Airless dispensing solutions offer safe reproducible dosing, con...
Aptar PharmaCompany NewsAptar Pharma co-organizer and diamond sponsor of RDD Europe 2019 conference in Estoril, PortugalAptar Pharma, the leader in respiratory drug delivery systems, is proud to announce its co- organiza...
Aptar PharmaCompany NewsAptar Pharma to host three insightful Learning Lab sessionsAptar Pharma will host three insightful Learning Lab sessions on Wednesday, February 5 at Pharmapack...
Aptar PharmaCompany NewsAptar Pharma acquires the assets of Cohero Health, further expanding its capabilities in digital healthAptarGroup, Inc., a global leader in consumer dispensing, active packaging, drug delivery solutions ...
Aptar PharmaCompany NewsAptar Pharma showcases expanded portfolio of respiratory innovations and servicesAptar Pharma has announced its Platinum Sponsorship of this year’s Drug Delivery to the Lung Confere...
Aptar PharmaCompany NewsAptar Seeks FDA Emergency Use Authorization for Decontaminating N95 Masks with ActivShieldAptarGroup, Inc. is seeking U.S. FDA Emergency Use Authorization (EUA) for a solution that allows ea...
Aptar PharmaProduct InfoAptar Pharma highlights expanded services platformAptar Pharma is highlighting its diverse portfolio of drug delivery systems, components and active p...
Aptar PharmaProduct InfoAptar Pharma launches PureHale, a new portable and ready-to-use upper respiratory drug delivery solutionAptar Pharma continues its commitment to meeting new market trends with the release of an industry f...
Aptar PharmaProduct InfoAptar Pharma Partners with Stallergenes Greer to Develop Novel Digital Health Ecosystem for Allergen Immunotherapy TreatmentThe innovative, easy-to-use connected drug delivery device and companion mobile app will contribute ...
Aptar PharmaProduct InfoNoble and Aptar Pharma launch AdhereIT, a connected medical device solution for disease management adherence and onboarding patientsNoble and Aptar Pharma are pleased to announce the launch of AdhereIT - a connected, intuitive and u...
Aptar PharmaProduct InfoAptar Pharma Partners with Lupin to launch India’s first connected smart device for respiratory disease, ADHEROAptar Pharma has partnered with Luin to launch India’s first connected device for metered-dose inhal...
Aptar PharmaProduct InfoAptar Pharma Launches HeroTracker SenseAptar Pharma, a global leader in drug delivery systems, services and active material science solutio...
Aptar PharmaYouTube VideoPADA (Powder Administration Device for Animals) - Starter kit for preclinical respiratory researchAptar Pharma’s PADA kit enables precise testing, development and screening of respiratory drugs. It'...
Aptar PharmaCompany NewsAptar acquires Nanopharm and Gateway Analytical, broadening pharma services platform to accelerate customer drug developmentAptarGroup, Inc. has announced that it has acquired two leading pharmaceutical services companies, N...
Aptar PharmaCompany NewsAptar Pharma's Nanopharm wins Excellence in Pharma Award for SmartTrackAptar Pharma's Nanopharm has won an Excellence in Pharma Award at the 2019 CPhI Pharma Awards. Nanop...
Aptar PharmaCompany NewsAptar Pharma to Unveil Inhalation Drug Delivery Solutions at CPhI China 2018Aptar Pharma, a leading drug delivery systems provider, is pleased to be exhibiting once again at CP...
Aptar PharmaCompany NewsAptar Pharma co-organizes the third edition of RDD AsiaAptar Pharma is pleased to announce the co-organization and its diamond sponsorship of the third Res...
Aptar PharmaProduct InfoAptar Pharma QuickStart, an injectable device development kit, to launch at CPhI WorldwideAptar Pharma, a leading provider of innovative drug delivery systems, in combination with Schott Gla...
Aptar PharmaProduct InfoAptar Pharma’s Nasal Unidose Device approved by US FDA for new nasal seizure rescue treatmentAptar Pharma has announced that its patented Unidose Liquid System is the device delivering a new na...
Aptar PharmaProduct InfoAptar Pharma QuickStart Injectables wins Industry Innovation Award at Pharmapack 2019Aptar Pharma, a leading provider of innovative drug delivery systems, has announced that their recen...
Aptar PharmaBrand LaunchNew FDA approved combination product with Aptar Pharma's VP3 nasal spray systemAptar Pharma, a global leader in drug delivery systems, services and active material science solutio...
Aptar PharmaBrand LaunchAptar Pharma’s preservative-free multidose dispenser approved in the US for Allergan’s REFRESH RELIEVA PF artificial tear formulationAptar Pharma has announced that its innovative, preservative-free multidose Ophthalmic Squeeze Dispe...
Aptar PharmaBrand LaunchAptar Pharma & Noble partner with dne pharma on Ventizolve nasal Naloxone treatmentAptar Pharma has announced a collaboration with dne pharma. Both companies are providing their nasal...
Aptar PharmaCompany NewsAptar Pharma to host live webinar on decoding the FDA's recent combination drug product guidanceAptar Pharma, a leading drug delivery systems provider, will host a live webinar on September 18, 20...
Aptar PharmaCompany NewsAptar Pharma is bringing the respiratory world togetherAptar Pharma is pleased to announce the co-organization and diamond sponsorship of the Respiratory D...
Aptar PharmaCompany NewsJoin Aptar Pharma's live webinar "Good medicine: Solutions for sensitive injectable formulations"Aptar Pharma, a leading provider of innovative drug delivery systems, will host a live educational w...
Aptar PharmaCompany NewsNew technologies in ophthalmic drug delivery webinar hosted by Aptar PharmaAptar Pharma, a leading provider of innovative drug delivery systems, has announced it will be hosti...
Aptar PharmaCompany NewsAptar Pharma showcases PureHale and QuickStartTM Injectables product launchesAs part of the Innovation Gallery at Pharmapack this year, Aptar Pharma will showcase two of their n...
Aptar PharmaCompany News Aptar Pharma's Preservative-Free Multidose Dispenser approved for anti-allergy treatment by French regulatory agency ANSMAptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved ...
Aptar PharmaProduct InfoAptar Pharma's nasal unidose device approved for Tosymra sumatriptan sprayAptar Pharma, a leading provider of drug delivery devices worldwide and part of AptarGroup, Inc. has...
Aptar PharmaProduct InfoAptar’s Nasal Unidose Device approved by US FDAAptarGroup, Inc, a global leader in dispensing and drug delivery solutions, has announced that its U...
Aptar PharmaProduct InfoAptar Pharma unveils innovative inhalation drug delivery solutionsAptar Pharma is introducing new market innovations in inhalation drug delivery for the Chinese marke...
Aptar PharmaYouTube VideoAptar Pharma - Improving Lives, Helping Customers SucceedAptar Pharma is a leading provider of innovative drug delivery systems for the world’s biggest brand...
Aptar PharmaCompany NewsAptar Pharma and RDD Online co-organize the second edition of RDD ASIA in Goa, IndiaAptar Pharma and RDD Online today announced the second Respiratory Drug Delivery (RDD®) Asia scienti...
Aptar PharmaCompany NewsAptar Pharma nears completion of elastomer component capacity in North AmericaAptar Pharma, a leading provider of drug delivery systems, is nearing completion on its expansion at...
Aptar PharmaCompany NewsPulmonary and nasal drug delivery experts to attend RDD Europe 2017Register now to attend the RDD Europe 2017 Scientific Conference to be held April 25-28, 2017, in A...
Aptar PharmaCompany NewsAptar Pharma's Freepod nasal spray device with GlaxoSmithKline's Otrivin wins prestigious WPO WorldStar 2019 awardAptar Pharma, a leading provider of innovative drug delivery systems, has announced that its patente...
Aptar PharmaCompany NewsPulmonary and Nasal Drug Delivery Experts to attend RDD Europe 2017The Respiratory Drug Delivery (RDD®) Europe 2017 scientific conference will welcome pulmonary and na...
.jpg)
.png)
 copy.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
